IWD vs XBI

iShares Russell 1000 Value ETF vs SPDR S&P Biotech ETF

Quick take
  • • IWD has the lower expense ratio at 0.18% vs 0.35% for XBI.
  • • IWD pays a higher dividend yield (1.37%).

Side-by-side metrics

MetricIWDXBI
Expense ratio
Annual fee. Lower is better.
0.18%0.35%
Dividend yield
Trailing 12-month yield.
1.37%0.35%
AUM
Assets under management — bigger funds are typically more liquid.
$83.22B$10.92B
YTD return
26.18%28.80%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.751.01
P/E ratio
20.67—
Last price
$263.33$156.41
Inception
——
Issuer
iSharesState Street

IWD top holdings

Top holdings · IWD
AAPLApple Inc6.03%
AMZNAmazon.com Inc5.64%
MSFTMicrosoft Corp5.12%
BRK-BBerkshire Hathaway Inc Class B2.67%
JPMJPMorgan Chase & Co2.38%
XOMExxonMobil Holdings Corp2.04%
JNJJohnson & Johnson1.74%
WMTWalmart Inc1.31%
ABBVAbbVie Inc1.27%
CVXChevron Corp1.15%
Sector breakdown · IWD
Real Estate3.5%
Consumer Cyclical10.1%
Basic Materials3.2%
Consumer Defensive7.7%
Technology20.8%
Communication Services2.9%
Financial Services18.2%
Utilities3.6%
Industrials9.6%
Energy6.8%
Healthcare13.7%

XBI top holdings

Top holdings · XBI
MRNAModerna Inc2.37%
NTRANatera Inc1.82%
HALOHalozyme Therapeutics Inc1.77%
TWSTTwist Bioscience Corp1.77%
BIIBBiogen Inc1.75%
AMGNAmgen Inc1.73%
EXELExelixis Inc1.73%
UTHRUnited Therapeutics Corp1.72%
ABBVAbbVie Inc1.71%
GILDGilead Sciences Inc1.70%
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%

About IWD

IWD (iShares Russell 1000 Value ETF) is Russell 1000 value stocks. Managed by iShares, the fund carries $83.2B in assets under management, an expense ratio of 0.18%, a dividend yield of 1.37%. Its largest holding is Apple Inc (AAPL), which represents 6.0% of the portfolio. Real Estate is the fund's largest sector exposure at 3.5%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.